Suppr超能文献

首例伴有 CXCR4 和 TRAF3 基因新突变的脾脏弥漫性红髓小 B 细胞淋巴瘤报告。

First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in CXCR4 and TRAF3 genes.

机构信息

Department of Hematology, Shaoxing People's Hospital, 568 Zhongxing North Road, ShaoxingShaoxing, 312000, Zhejiang Province, China.

Department of Hepatobiliary Surgery, Shaoxing People's Hospital, Shaoxing, China.

出版信息

Int J Hematol. 2023 Sep;118(3):394-399. doi: 10.1007/s12185-023-03581-3. Epub 2023 Mar 19.

Abstract

Splenic diffuse red pulp small B-cell lymphoma (SDRPL) is a rare B-cell tumor whose genetic characteristics are poorly understood. Here, we introduce the case of a 62-year-old patient with SDRPL who showed progressive elevation of lymphocytes and progressive spleen enlargement. Immunohistochemistry showed that CD20 and CD79a were positive, and the Ki-67 labelling index was approximately 5%, consistent with the pathological features of splenic B-cell lymphoma. Spleen tissue and peripheral blood samples from the patient were sequenced using a next-generation sequencing platform, and mutations possibly were detected in the CXCR4 and TRAF3 genes that may be related to the pathogenesis of the disease. This finding may provide insights into the molecular pathogenesis of SDRPL and assist in molecular diagnosis and targeted therapy for SDRPL.

摘要

脾脏弥漫性红髓小 B 细胞淋巴瘤(SDRPL)是一种罕见的 B 细胞肿瘤,其遗传特征尚未完全阐明。本研究介绍了一例 SDRPL 患者,该患者 62 岁,表现为淋巴细胞进行性升高和脾脏进行性肿大。免疫组化结果显示 CD20 和 CD79a 阳性,Ki-67 标记指数约为 5%,符合脾 B 细胞淋巴瘤的病理特征。采用下一代测序平台对患者的脾组织和外周血样本进行测序,可能在 CXCR4 和 TRAF3 基因中检测到突变,这些突变可能与疾病的发病机制有关。这一发现可能为 SDRPL 的分子发病机制提供新的见解,并有助于 SDRPL 的分子诊断和靶向治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验